The Clinical Trial of Chinese Herbal Medicine SaiLuoTong Capsule
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 372 participants.
Also called NCT01978730
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 372 participants
- Sponsor
- Shineway Pharmaceutical Co.,Ltd
- Registry
-
NCT01978730
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT01978730. Randomized; quadruple masking; primary purpose treatment. Start 2011-12 (registry gives no type); primary completion 2014-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Clinical Trial of Chinese Herbal Medicine SaiLuoTong Capsule
- Condition
- Vascular Dementia
- Intervention (Drug)
- high dose group of SaiLuoTong capsule
- Intervention (Drug)
- low dose group of SaiLuoTong
- Intervention (Drug)
- the control group
- Lead sponsor
- Shineway Pharmaceutical Co.,Ltd
Record details
- Record id
cardio:ct-nct01978730- Content hash
c6884c09ae5559c83c5538cc52dbcb09963da9737d5efa7fa8113a2e679fd68a